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We investigated the zoonotic potential of Waddlia chon-
drophila, a new Chlamydia-like abortigenic agent in rumi-
nants. Anti-Waddlia antibody reactivity was tested by immu-
nofl uorescence and Western blot. Waddlia seroprevalence 
was higher in women who had had sporadic and recurrent 
miscarriages than in control women (p<0.001). Waddlia 
spp. may represent a cause of human fetal loss.
Approximately 15% of pregnancies end in miscarriage (1). However, a cause is identifi ed in only 50% of 
these cases. Obligate intracellular bacteria, which fail to 
grow on media used routinely to isolate human pathogens, 
could represent yet unrecognized agents of miscarriage.
Chlamydia trachomatis, an intracellular bacterium, is 
the world’s most common sexually transmitted bacterial 
pathogen (2). Because C. trachomatis is asymptomatic, 
most infected women remain untreated. Although the ef-
fect of C. trachomatis infection on pregnancy outcome is 
unclear, an increased prevalence of C. trachomatis immu-
noglobulin (Ig) G antibodies in women with a history of 
miscarriage has been observed (2,3). Chlamydophila abor-
tus is the most common etiology of abortion in ruminants 
(4) and can also cause miscarriage in pregnant women ex-
posed to infected animals.
Waddlia chondrophila, another Chlamydiales, is a new 
abortigenic agent in bovines (5,6). This obligate intracellu-
lar bacterium was isolated from aborted fetuses in the Unit-
ed States (7) and in Germany (8). A serologic study further 
supported the abortigenic role of Waddlia in bovine species 
(6). Moreover, infection of bovine fetuses with Waddlia 
was associated with their deaths within 2 weeks (6). In this 
study, we tested women with sporadic and recurrent mis-
carriages for antibody reactivity against Waddlia and com-
pared seroprevalence with that found in a control group of 
women with uneventful term pregnancies.
The Study
From July 2004 to March 2005, we studied 69 women 
with sporadic miscarriages (SM), 200 women who had suf-
fered from recurrent miscarriages (RM), and 169 control 
women who had had uneventful pregnancies (Table 1). The 
RM group comprised women who had >3 miscarriages (1) 
and who had attended the Recurrent Miscarriage Clinic of 
St Mary’s Hospital, London, the largest specialist referral 
center in Europe. 
Immunofl uorescence tests were performed (9); we 
used W. chondrophila strain ATCC VR-1470 as antigen 
and we screened sera at a 1:64 dilution with FluolineH 
(bioMerieux, Marcy l’Etoile, France). Antigen was iso-
lated as described (10,11). Mice and rabbit anti-Waddlia 
antibodies were used as positive controls with a fl uores-
cein-conjugated anti-mouse and anti-rabbit globulin. Sera 
that exhibited an Ig titer >64 were tested for IgG and IgM 
reactivity by using corresponding anti-human Ig fl uoresce-
in (FluolineG or FluolineM, bioMérieux) and serial 2-fold 
dilutions of serum. IgG and IgM positivity cut-offs were 
>1:64 and >1:32, as proposed for other chlamydia-like or-
ganisms (4). One hundred women had an anti-Waddlia IgG 
titer >64 (Table 1). Seroprevalence was higher for patients 
who had sporadic (31.9%) and recurrent (33%) miscar-
riages than that for women who had had uneventful preg-
nancies (7.1%, p<0.001 when comparing either SM or RM 
groups to controls). One woman had a positive IgM titer of 
64 and an IgG titer of 512. 
To confi rm the specifi city of immunofl uorescence, we 
performed Western blot analyses on all Waddlia-positive 
sera samples. Western blot was performed (9), but Waddlia 
was used as the antigen. A polyclonal peroxidase-labeled 
anti-human IgG (Dako, Glostrup, Denmark) was used as 
a secondary antibody. The presence of anti-Waddlia IgG 
antibodies was confi rmed by Western blot in 97 of the 100 
positive samples by immunofl uorescence (Table 1; Figure 
1, panels B and C). By using Waddlia spp. hyperimmune 
mouse and rabbit sera and corresponding peroxidase-con-
jugated anti-mouse/rabbit sera, we obtained similar pat-
terns of 61-, 55-, 53-, 45-, 41-, 38- and 30-kDa proteins 
(Figure 1, panels D and E). Antibody reactivity against the 
55-, 53-, 45-, 41- and 38-kDa proteins disappeared after 
adsorption with 108 Waddlia antigen for 48 hours, which 
demonstrated the specifi city of the antibody response (Fig-
ure 1, panel F).
For further statistical analyses, only patients whose 
samples were positive for Waddlia spp. by immunofl uo-
rescence and confi rmed by Western blot were considered 
seropositive for Waddlia spp. (n = 97). In all age groups, 
the rate of Waddlia seropositivity was higher in patients 
who had miscarried than in those who had not (data not 
shown). Moreover, most women with anti-Waddlia anti-
bodies did not exhibit serologic reactivity against C. tra-
chomatis (Table 2).
In a multivariate logistic regression adjusted for age, 
ethnicity, contact with animals and C. trachomatis serosta-
tus (Figure 2), miscarriage (SM/RM) remained strongly 
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associated with Waddlia seropositivity (odds ratio [OR] 
4.9, 95% confi dence interval [CI] 2.5–9.4). In this model, 
miscarriage was also independently associated with age 
(OR 2.9, 95% CI 2.0–4.1) and C. trachomatis seropositivity 
(OR 2.3, 95% CI 1.2–4.5). Additional multivariate models 
confi rmed the association between Waddlia IgG seroposi-
tivity and miscarriage, with ORs ranging from 4.9 to 6.2.
Noninfectious causes of miscarriage have also been 
recorded (Table 2). When studying only the 322 patients 
without known concurrent conditions, the strong correla-
tion between Waddlia seropositivity and miscarriage was 
still present (68/195 [34.8%] of patients who had had a 
miscarriage vs. 10/127 [7.9%] of patients who had not mis-
carried had anti-Waddlia antibodies; p<0.001). 
Waddlia seropositivity was associated with early 
miscarriage (p<0.001, Table 2). No difference in ethnic-
ity was observed between those who were IgG positive 
for Waddlia spp. and those who were negative. Moreover, 
there was no difference in C. trachomatis, Chlamydophila 
pneumoniae, or Cp. psittaci seropositivity between women 
who had anti-Waddlia antibodies and those who did not, 
which suggests that Waddlia antibodies do not cross-react 
with Chlamydiaceae. Moreover, only 7 (1.6%) of 438 pa-
tients had a Parachlamydia IgG titer >64. With such a low 
Table 1. Characteristics of study patients according to miscarriage history* 
Characteristics
Controls (n = 169), 
no. (%) 
Sporadic miscarriages
(n = 69), no. (%, p value†) 
Recurrent miscarriages 
(n = 200), no. (%, p value†) 
Age, y 
 Median (IQR, p value†) 30.4 (25–35) 31.7 (27–36, 0.18) 35.4 (31–39, <0.001) 
No. pregnancies 
 1 90 (53.3) 32 (46.4) 0
 2 46 (27.2) 19 (27.5, 0.67‡) 0 (0, <0.001‡) 
 >2 33 (19.5) 18 (26.1) 200 (100) 
 Mean (SD, p value†) 1.8 (1.1) 2.1 (1.5, 0.23) 5.2 (3, <0.001) 
Parity 
 0 0 (0) 49 (71) 113 (56.5) 
 1 115 (68.1) 11 (15.9, <0.001‡) 59 (29.5, <0.001‡) 
 2 31 (18.3) 4 (5.8) 19 (9.5) 
 >2 23 (13.6) 5 (7.3) 9 (4.5) 
 Mean (SD, p value†) 1.54 (0.95) 0.52 (1.01, <0.001) 0.64 (0.9, <0.001) 
Miscarriages
 Early (<12 weeks) 0 52 (75.4, <0.001) 196 (98, <0.001) 
 Late (>12 weeks) 0 13 (18.9, <0.001) 51 (25.5, <0.001) 
 Stillbirth (>24 weeks) 0 4 (5.8, <0.001) 11 (5.5, 0.002) 
 Alive child 169 (100) 21 (30.4, <0.001) 78 (39, <0.001) 
Ethnicity 
 White 80 (47.3) 34 (49.3, 0.79) 132 (66, <0.001) 
 Black 35 (20.7) 10 (14.5, 0.27) 22 (11, 0.01) 
 Asian 31 (18.3) 18 (26.1, 0.18) 34 (17, 0.74) 
 Other 22 (13) 6 (8.7, 0.35) 8 (4, 0.002) 
Contact with animals 29 (17.2) 11 (15.9, 0.82) 70 (35, <0.001) 
 Cat 18 (10.7) 5 (7.3, 0.42) 37 (18.5, 0.035) 
 Dog 15 (8.9) 6 (8.7, 0.97) 28 (14, 0.13) 
 Fish 1 (0.6) 0 (0, 1) 8 (4, 0.043) 
 Rodents 0 2 (2.9, 0.08) 7 (3.5, 0.017) 
 Other 3 (1.8) 0 (0, 0.63) 12 (6, 0.041) 
Chlamydia trachomatis  (IgG titer>50) 15 (8.9) 9 (13, 0.33) 39 (19.5, 0.004) 
Positive serology for Waddlia spp. 
 IgG titer >64 12 (7.1) 22 (31.9, <0.001) 66 (33, <0.001) 
 IgG titer >128 6 (3.6) 10 (14.5, 0.002) 29 (14.5, <0.001) 
Western blot Waddlia IgG 
<1 band 12 (7.1) 22 (31.9, <0.001) 63 (31.5, <0.001) 
<2 bands 6 (3.6) 15 (21.7, <0.001) 51 (25.5, <0.001) 
<3 bands 3 (1.8) 9 (13, <0.001) 28 (14, <0.001) 
<2 specific bands§ 1 (0.6) 9 (13, <0.001) 22 (11, <0.001) 
*Controls, women with uneventful pregnancies; IQR, interquartile range. 
†Compared with control group. 
‡p value for ordered categories (Pearson χ2 test). 
§According to Waddlia hyperimmune mouse serum, bands at 61-, 55-, 53-, 45-, 41-, 38-, and 30-kDa are considered specific for Waddlia spp. 
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Table 2. Characteristics of patients in the study according to their Waddlia serostatus 
Waddlia negative* (n = 341) Waddlia positive† (n = 97) p value 
Age, y 
 Median (interquartile range) 33 (28–37) 36 (31–39) <0.001
No. pregnancies 
 1 107 (31.4) 15 (15.5) 
 2 62 (18.2) 16 (16.5) 0.006‡
 >2 172 (50.4) 66 (68) 
 Mean (SD) 3.2 (2.6) 4 (3.1) 0.005
Parity 
 0 108 (31.7) 54 (55.7) 
 1 156 (45.8) 29 (29.9) 
 2 49 (14.4) 5 (5.2) 
0.001‡
 >2 28 (8.2) 9 (9.3) 
 Mean (SD) 1.04 (1.04) 0.7 (1) <0.001
Miscarriages
 Early (<12 wk) 170 (49.9) 81 (83.5) <0.001
 Late (>12 wk) 47 (13.8) 17 (17.5) 0.36
 Stillbirth (>24 wk) 12 (3.5) 3 (3.1) 1
 Alive child 228 (66.9) 40 (41.2) <0.001
Ethnicity 
 White 184 (54) 62 (63.9) 0.08
 Black 52 (15.3) 15 (15.5) 0.96
 Asian 70 (20.5) 13 (13.4) 0.11
 Other 29 (8.5) 7 (7.2) 0.68
Contact with animals 76 (22.3) 34 (35.1) 0.011
 Cat 42 (12.3) 18 (18.6) 0.12
 Dog 35 (10.3) 14 (14.4) 0.25
 Fish 6 (1.8) 3 (3.1) 0.42
 Rodent 7 (2.1) 2 (2.1) 1
 Other 12 (3.5) 3 (3.1) 1
Noninfectious miscarriage causes 97 (28.5) 19 (19.6) 0.08
 Autoimmune disease 19 (5.6) 1 (1) 0.09
 Hypertensive disorder 8 (2.4) 3 (3.1) 0.71
 Endocrine pathology 13 (3.8) 2 (2.1) 0.54
 Anatomic abnormalities 4 (1.2) 2 (2.1) 0.62
Additional serologies (titers) 
 Chlamydia trachomatis (IgG>50) 49 (14.7) 14 (14.3) 0.98
 Clamydophila pneumoniae (IgG>64) 161 (47.2) 38 (39.2) 0.16
 Cp. psittaci (IgG>1/64) 20 (5.9) 6 (6.2) 1
*Patients with a Waddlia immunoglobulin G (IgG) titer <64 (n = 338) or not confirmed by Western blot analysis (n = 3). 
†Patients with a Waddlia IgG titer >64 and confirmed by Western blot analysis. 
‡p value for ordered categories (Pearson χ2 test). 
Figure 1. Western blot analyses. A) Molecular weight 
and frequency of IgG reactivity of Waddlia proteins, 
as determined by Western blots. B) and C) Four 
representative Western blot patterns of Waddlia IgG 
positive sera from recurrent and sporadic miscarriage 
groups. D) and E) Representative Western blot 
pattern of positive control (Waddlia hyper-immune 
mouse and rabbit serum, respectively). F) Western 
blot performed with Waddlia IgG positive sera, taken 
from patients who had miscarried before (b) and after 
(a) adsorption with Waddlia antigen. MW, molecular 
weight; nb, number. 
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Parachlamydia prevalence, cross-reactivity with this chla-
mydia-like organism is unlikely to explain the high Wad-
dlia seroprevalence observed in the miscarriage groups.
Women who were IgG seropositive for Waddlia spp. 
were more likely to have had contact with animals. In a 
multivariate logistic regression model adjusted for age, eth-
nicity, and C. trachomatis serostatus, those who had had 
previous contact with animals were more likely to exhibit 
anti-Waddlia antibodies (OR 1.7, 95% CI 1.0–2.9, Figure 
2). In this model, Waddlia IgG–positive serologic test re-
sults were also independently associated with age (OR 2.1, 
95% CI 1.4–3.1). 
Conclusions
This study demonstrates a strong association between 
the presence of W. chondrophila–specifi c IgG antibodies 
and early fetal loss. Cross-reactivity with other microor-
ganisms seems an unlikely explanation for our results be-
cause W. chondrophila did not react with monoclonal or 
polyclonal antisera directed against Rickettsia, Coxiella, 
Wolbachia, Anaplasma, and Chlamydia spp. (8,12). We 
did not detect any cross-reactivity of W. chondrophila with 
C. trachomatis, Cp. pneumoniae, and Cp. psittaci. More-
over, the molecular weights of Waddlial immunoreactive 
proteins obtained by Western blot are clearly different than 
those reported for C. trachomatis or Cp. pneumoniae (13). 
With the exception of 1 patient who had IgM, only IgG 
antibody reactivity against W. chondrophila was observed. 
Because IgG antibodies may persist for years after an acute 
infection has resolved (3), the underlying mechanism of 
miscarriage due to W. chondrophila may involve reactiva-
tion of a latent asymptomatic waddlial infection, endome-
trial damage from a past waddlial infection, or an immune 
response to an epitope shared by a waddlial and fetal anti-
gen, as proposed for C. trachomatis (3).
The association we found between contact with ani-
mals and positive serologic results for Waddlia spp. raises 
the zoonotic potential of this bacterium. This hypothesis 
is further supported by the range of hosts for Waddliaceae 
(4). Other modes of transmission are possible (e.g., con-
taminated water) because free-living amebae may serve as 
hosts for Waddlia spp. (14) and are widespread in water net-
works (15). Waddlia spp. may also be transmitted through 
ingestion of contaminated cow milk. Finally, Waddlia spp. 
might represent a sexually transmitted disease.
Further investigations are urgently needed to defi ne 
how Waddlia spp. infection may be acquired. To confi rm 
the role of W. chondrophila in miscarriage, it will be impor-
tant to isolate this intracellular bacterium from miscarriage 
products or confi rm its presence in the placenta by immu-
nohistochemistry or PCR. This may be diffi cult to achieve, 
if, as suggested for C. trachomatis (3), W. chondrophila 
causes miscarriage indirectly, e.g., through increased cyto-
kine production or molecular mimicry with fetal antigens. 
To our knowledge, this work provides the fi rst evidence 
that W. chondrophila may be implicated in human fetal 
death.
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Figure 2. Multivariate analyses. A) Multivariate analysis adjusted 
for all variables listed in this fi gure and showing the independent 
association of age, positive Waddlia serologic results and positive 
Chlamydia trachomatis serologic results for women who had had a 
miscarriage.  B) Multivariate analysis adjusted for all variables listed 
in this fi gure and showing the independent association of animal 
contact and advancing age with serologic evidence of Waddlia 
infection. *, seropositivity; †, odds ratio for Waddlia seropositivity.
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